Aspire BioPharma, Inc. Cash Flow Quality Index
Aspire BioPharma, Inc. cash flow quality index. Aspire BioPharma, Inc. (ASBP) has a Cash Flow Quality Index of -0.10x as of June 2023. Operating cash flow of $-189.95K is below net income of $1.81 Million, suggesting accrual-heavy earnings not yet converted to cash. See Aspire BioPharma, Inc. (ASBP) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aspire BioPharma, Inc. (2023–2023)
Cash flow quality index of Aspire BioPharma, Inc. from 2023 to 2023. Historical Cash Flow Quality Index for Aspire BioPharma, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ASBP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Aspire BioPharma, Inc. Cash Flow Quality Index by Year (2023–2023)
Aspire BioPharma, Inc. cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Aspire BioPharma, Inc.. For the full cash flow conversion analysis, see Aspire BioPharma, Inc. cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.15x | $-653.11K | $4.46 Million | — |